Current challenges in the management of breast cancer brain metastases von O’Sullivan, Ciara C., Davarpanah, Nicole N., Abraham, Jame, Bates, Susan E.

Volltext

Immunotherapy: a new treatment paradigm in bladder cancer von Davarpanah, Nicole N, Yuno, Akira, Trepel, Jane B, Apolo, Andrea B

Volltext

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial von Bellmunt, Joaquim, Hussain, Maha, Gschwend, Jürgen E, Albers, Peter, Oudard, Stephane, Castellano, Daniel, Daneshmand, Siamak, Nishiyama, Hiroyuki, Majchrowicz, Martin, Degaonkar, Viraj, Shi, Yi, Mariathasan, Sanjeev, Grivas, Petros, Drakaki, Alexandra, O'Donnell, Peter H, Rosenberg, Jonathan E, Geynisman, Daniel M, Petrylak, Daniel P, Hoffman-Censits, Jean, Bedke, Jens, Kalebasty, Arash Rezazadeh, Zakharia, Yousef, van der Heijden, Michiel S, Sternberg, Cora N, Davarpanah, Nicole N, Powles, Thomas

Volltext

1O Clinical outcomes in post-operative ctDNA-positive muscle-invasive urothelial carcinoma (MIUC) patients after atezolizumab adjuvant therapy von Powles, T.B., Assaf, Z.J., Davarpanah, N., Hussain, M., Oudard, S., Gschwend, J.E., Albers, P., Castellano, D., Nishiyama, H., Daneshmand, S., Grivas, P., Sharma, S., Sethi, H., Aleshin, A., Zhang, J., Degaonkar, V., Bais, C., Carter, C.A., Bellmunt, J., Mariathasan, S.

Volltext

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors von Apolo, Andrea B, Nadal, Rosa, Girardi, Daniel M, Niglio, Scot A, Ley, Lisa, Cordes, Lisa M, Steinberg, Seth M, Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Mallek, Marissa, Davarpanah, Nicole N, Costello, Rene, Trepel, Jane B, Lee, Min-Jung, Merino, Maria J, Bagheri, Mohammad Hadi, Monk, Paul, Figg, William D, Gulley, James L, Agarwal, Piyush K, Valera, Vladimir, Chalfin, Heather J, Jones, Jennifer, Streicher, Howard, Wright, John J, Ning, Yangmin M, Parnes, Howard L, Dahut, William L, Bottaro, Donald P, Lara, Jr, Primo N, Saraiya, Biren, Pal, Sumanta K, Stein, Mark N, Mortazavi, Amir

Volltext

Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literature von Cordes, Lisa M., Davarpanah, Nicole N., Reoma, Lauren B., Gasmi, Billel, Quezado, Martha, Khan, Omar I., Nath, Avindra, Apolo, Andrea B.

Volltext

Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial von Apolo, Andrea B, Nadal, Rosa, Tomita, Yusuke, Davarpanah, Nicole N, Cordes, Lisa M, Steinberg, Seth M, Cao, Liang, Parnes, Howard L, Costello, Rene, Merino, Maria J, Folio, Les R, Lindenberg, Liza, Raffeld, Mark, Lin, Jeffrey, Lee, Min-Jung, Lee, Sunmin, Alarcon, Sylvia V, Yuno, Akira, Dawson, Nancy A, Allette, Kimaada, Roy, Arpita, De Silva, Dinuka, Lee, Molly M, Sissung, Tristan M, Figg, William D, Agarwal, Piyush K, Wright, John J, Ning, Yangmin M, Gulley, James L, Dahut, William L, Bottaro, Donald P, Trepel, Jane B

Volltext

IMvigor010: Primary analysis from a phase III randomized study of adjuvant atezolizumab (atezo) versus observation (obs) in high-risk muscle-invasive urothelial carcinoma (MIUC) von Hussain, Maha H. A., Powles, Thomas, Albers, Peter, Castellano, Daniel, Daneshmand, Siamak, Gschwend, Juergen, Nishiyama, Hiroyuki, Oudard, Stephane, Tayama, Darren, Davarpanah, Nicole N., Degaonkar, Viraj, Shi, Yi, Mariathasan, Sanjeev, Grivas, Petros, O'Donnell, Peter H., Rosenberg, Jonathan E., Geynisman, Daniel M., Hoffman-Censits, Jean H., Petrylak, Daniel Peter, Bellmunt, Joaquim

Volltext

ANG1005 for breast cancer brain metastases: correlation between 18F-FLT–PET after first cycle and MRI in response assessment von O’Sullivan, C. C., Lindenberg, M., Bryla, C., Patronas, N., Peer, C. J., Amiri-Kordestani, L., Davarpanah, N., Gonzalez, E. M., Burotto, M., Choyke, P., Steinberg, S. M., Liewehr, D. J., Figg, W. D., Fojo, T., Balasubramaniam, S., Bates, S. E.

Volltext

Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma von Kurtoglu, Metin, Davarpanah, Nicole N, Qin, Rui, Powles, Thomas, Rosenberg, Jonathan E, Apolo, Andrea B

Volltext

Filtration of contaminated suspended solids for the treatment of surface water von Mulligan, Catherine N., Davarpanah, Neginmalak, Fukue, Masaharu, Inoue, Tomohiro

Volltext

Final results of a phase I study of cabozantinib (cabo) plus nivolumab (nivo) and cabonivo plus ipilimumab (Ipi) in patients (pts) with metastatic urothelial carcinoma (mUC) and ot... von Nadal, R., Mortazavi, A., Stein, M., Pal, S.K., Davarpanah, N., Parnes, H.L., Ning, Y.M., Cordes, L.M., Lin, J., Bagheri, M., Linderberg, L., Berniger, M., Steinberg, S.M., Moore, T., Lancaster, T., Aviles, M., Costello, R., Bottaro, D.P., Dahut, W.L., Apolo, A.B.

Volltext

A phase I study of cabozantinib plus nivolumab (CaboNivo) in patients (pts) refractory metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors von Apolo, A.B., Mortazavi, A., Stein, M., Pal, S.K., Davarpanah, N., Parnes, H.L., Ning, Y.M., Francis, D.C., Cordes, L.M., Berniger, M., Steinberg, S.M., Monk, P., Lancaster, T., Mayer, T., Costello, R., Bottaro, D.P., Dahut, W.L.

Volltext

IMvigor010: Updated analysis of Overall Survival (OS) by circulating tumour DNA (ctDNA) status in patients with post-operative Muscle-Invasive Urothelial Carcinoma (MIUC) treated w... von Powles, T., June Assaf, Z., Mariathasan, S., Hussain, M., Oudard, S., Albers, P., Castellano, D., Nishiyama, H., Daneshmand, S., Grivas, P., Sharma, S., Sethi, H., Aleshin, A., Degaonkar, V., Shi, Y., Davarpanah, N., Carter, C.A., Bellmunt, J., Gschwend, J.E.

Volltext

ANG1005 for breast cancer brain metastases: correlation between super(18)F-FLT-PET after first cycle and MRI in response assessment von O'Sullivan, C C, Lindenberg, M, Bryla, C, Patronas, N, Peer, C J, Amiri-Kordestani, L, Davarpanah, N, Gonzalez, E M, Burotto, M, Choyke, P, Steinberg, S M, Liewehr, D J, Figg, W D, Fojo, T, Balasubramaniam, S, Bates, SE

Volltext

ANG1005 for breast cancer brain metastases: correlation between ^sup 18^F-FLT-PET after first cycle and MRI in response assessment von O'sullivan, C C, Lindenberg, M, Bryla, C, Patronas, N, Peer, C J, Amiri-kordestani, L, Davarpanah, N, Gonzalez, E M, Burotto, M, Choyke, P, Steinberg, S M, Liewehr, D J, Figg, W D, Fojo, T, Balasubramaniam, S, Bates, S E

Volltext

ANG1005 for breast cancer brain metastases: correlation between .sup.18F-FLT-PET after first cycle and MRI in response assessment von O'Sullivan, C. C, Lindenberg, M, Bryla, C, Patronas, N, Peer, C. J, Amiri-Kordestani, L, Davarpanah, N, Gonzalez, E. M, Burotto, M, Choyke, P, Steinberg, S. M, Liewehr, D. J, Figg, W. D, Fojo, T, Balasubramaniam, S, Bates, S. E

Volltext

Molecular residual disease (MRD) detection with a tissue comprehensive genomic profiling (CGP)-informed personalized monitoring assay: An exploratory analysis of the IMvigor-010 ob... von Young, Amanda, Nimeiri, Halla, Madison, Russell, Fine, Alexander D., Zollinger, Daniel, Gjoerup, Ole, Aushev, Vasily N., Wu, Hsin-Ta, Aleshin, Alexey, Davarpanah, Nicole N., Assaf, Zoe, Mariathasan, Sanjeev, Oxnard, Geoffrey R., Renkonen, Elise, Powles, Thomas, Hegde, Priti

Volltext

Atezolizumab (atezo) with or without Bacille Calmette-Guérin (BCG) in patients (pts) with high-risk nonmuscle-invasive bladder cancer (NMIBC): Results from a phase Ib/II study von Hahn, Noah M., Steinberg, Gary D., Stratton, Kelly Lynn, Kopp, Ryan P., Sankin, Alexander, Skinner, Eila C., Pohar, Kamal S., Gartrell, Benjamin Adam, Pham, Song, Rishipathak, Deepali, Mariathasan, Sanjeev, Davarpanah, Nicole N., Carter, Corey, Inman, Brant Allen

Volltext

Treatment (tx) characteristics of patients (pts) with locally advanced or metastatic urothelial cancer (mUC) receiving checkpoint inhibitor (CPI) monotherapy in a US clinical pract... von Morgans, Alicia K., Rahma, Osama E., Mhatre, Shivani K., Chuo, Ching-Yi, Davies, Jessica, Martinalbo, Jorge, Davarpanah, Nicole N., Pachynski, Russell

Volltext